Living Cell Technologies Limited

Living Cell Technologies Limited

LCT is a cell-based biotechnology developing insulin producing porcine pancreatic islets for the treatment of type 1 diabetes . LCT's lead product, DIABECELL is in Phase II clinical trial. LCT's encap...

Living Cell Technologies Limited's Basic Information

Headquarters
Auckland, New Zealand
Headcount
11 - 50
Specialties
Cell-based biotechnology

Living Cell Technologies Limited's Competitors

Empire Medicinals, Inc.
Empire Medicinals, Inc.

Rochester, Illinois, United States

Greenway Holdings INC
Greenway Holdings INC

Harvard Clinical Technology
Harvard Clinical Technology

Natick, Massachusetts, United States

Eastern Research Solutions
Eastern Research Solutions

Oxford Cancer Biomarkers
Oxford Cancer Biomarkers

Oxford, England, United Kingdom

Employee Insights

Employee Function

Employee Location

Living Cell Technologies Limited's Top Employees

people
Janice Lam
Head of Operations
people
Bob Elliott
Medical Director
people
John Cowan
Head OF Finance AND Administration
people
David Collinson
Founding Director
people
Jonathan Lane
Administrator Manager

Find Your Next Customer with Better Data

Get access to over 160 million contacts and companies' information in AroundDeal's B2B database, quickly build highly targeted prospect lists and directly reach the buying committee.

Top-ranked on G2 Crowd
🛡️GDPR compliantCancel anytime
Free credits every month!

Frequently Asked Questions Regarding Living Cell Technologies Limited

Where is Living Cell Technologies Limited's headquarter located?

Living Cell Technologies Limited's headquarter are located at New Zealand.

How many employees does Living Cell Technologies Limited have?

Living Cell Technologies Limited has 11 - 50 employees.

What is Living Cell Technologies Limited's official website?

Living Cell Technologies Limited's official website is http://lctglobal.com

What does Living Cell Technologies Limited do?

LCT is a cell-based biotechnology developing insulin producing porcine pancreatic islets for the treatment of type 1 diabetes . LCT's lead product, DIABECELL is in Phase II clinical trial. LCT's encap...

What specialty does Living Cell Technologies Limited have?

Cell-based biotechnology

Connect with anyone with AroundDeal today!

Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
cta